Back to UBS Group AG UBS Group AG

RADXRADX
6 quarters

Position history for UBS Group AGUBS Group AG's holdings in Radiopharm Theranostics

UBS Group AG holds 3,000 shares of RADX (Radiopharm Theranostics), worth $12,900 as of 2026-Q1. The position was decreased (-79.0% shares).

Current Value

$12,900

Current Shares

3,000

Total Value Change

+$6,987

Total Shares Change

+1,683

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
3,000
-79.0%
$12,9000.0%$4.86
0
2025-Q4
Decreased
14,277
-21.5%
$74,5260.0%$5.16
0
2025-Q3
Increased
18,191
+2.5%
$100,4140.0%$5.80
15
2025-Q2
New
17,740
-
$82,3140.0%$4.72
33
2025-Q1
Exited
0
-100.0%
$00.0%$5.40
0
2024-Q4
New
1,317
-
$5,9130.0%$4.80
24

Other major holders of RADX: HSBC HOLDINGS PLC, PNC FINANCIAL SERVICES GROUP, INC., Virtu Financial LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used